Daily Archives: December 1, 2020
IDSA 2020 Guidelines for the prevention, diagnosis and treatment of Lyme disease
1 Dec, 2020 | 08:28h | UTC
WHO World malaria report 2020: 20 years of global progress & challenges
1 Dec, 2020 | 08:27h | UTCWorld malaria report 2020: 20 years of global progress & challenges – World Health Organization
News Release: WHO calls for reinvigorated action to fight malaria
Cohort study: Higher dose Z-drug use in dementia is associated with increased fracture and stroke risks, similar or greater to that for higher dose benzodiazepines
1 Dec, 2020 | 08:25h | UTCCommentary: The danger of Z-drugs for dementia patients – University of Exeter
NICE COVID-19 guideline: Prevention of thromboembolism in patients with COVID-19. “For patients who are having advanced respiratory support: consider increasing pharmacological VTE prophylaxis to an intermediate dose”
1 Dec, 2020 | 08:19h | UTC
Moderna released more Covid-19 vaccine results. They’re very encouraging.
1 Dec, 2020 | 08:15h | UTCModerna released more Covid-19 vaccine results. They’re very encouraging. – Vox
Commentaries: ‘Absolutely remarkable’: No one who got Moderna’s vaccine in trial developed severe COVID-19 – Science AND Moderna to submit Covid-19 vaccine to FDA as full results show 94% efficacy – STAT AND More Good News For Moderna’s COVID-19 Vaccine Candidate – NPR AND Moderna to seek emergency authorization for COVID-19 vaccine – CIDRAP
Commentary on Twitter
Moderna has announced the final results of the 30,000-person efficacy trial for its #COVID19 vaccine candidate, reporting that the vaccine had 100% efficacy against severe disease. https://t.co/Cgg0I5nv9r
— News from Science (@NewsfromScience) November 30, 2020
Comprehensive review on the management of pharmaceutical and recreational drug poisoning
1 Dec, 2020 | 08:21h | UTCManagement of pharmaceutical and recreational drug poisoning – Annals of Intensive Care
Opinion: How Prestige Journals Remain Elite, Exclusive and Exclusionary. “by announcing a €9,500 price tag, Nature has failed to enact their own diversity and inclusion pledge”
1 Dec, 2020 | 08:22h | UTCHow Prestige Journals Remain Elite, Exclusive And Exclusionary – Forbes
See also: For €9500, Nature journals will now make your paper free to read
Opinion: Pfizer and Moderna’s “95% effective” vaccines—let’s be cautious and first see the full data
1 Dec, 2020 | 08:13h | UTC
Colchicine to be investigated as a possible treatment for COVID-19 in the RECOVERY trial
1 Dec, 2020 | 08:08h | UTCCommentary: Gout drug Colchicine to be tested as COVID-19 treatment in UK trial – Reuters
Critically ill patients with COVID-19: A narrative review on prone position
1 Dec, 2020 | 08:07h | UTCCritically Ill Patients with COVID-19: A Narrative Review on Prone Position – Pulmonary Therapy
The Ioannidis affair: A tale of major scientific overreaction
1 Dec, 2020 | 08:10h | UTCThe Ioannidis Affair: A Tale of Major Scientific Overreaction – Scientific American
The COVID science wars: Shutting down scientific debate is hurting the public health
1 Dec, 2020 | 08:11h | UTCThe COVID Science Wars – Scientific American
AstraZeneca vaccine most attractive option for Africa, says WHO – Astra Zeneca CEO says company will run new trial to test more efficient dose
1 Dec, 2020 | 08:05h | UTC